Related Experiment Video
Updated: May 5, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Acute decompensated heart failure update
John R Teerlink, Khalid Alburikan, Marco Metra
1Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, CB# 7569, Chapel Hill, NC 27599, USA. jerodgers@unc.edu.
Insights
Acute decompensated heart failure (ADHF) is rising, increasing hospitalizations and costs. This review updates clinicians on the optimal evaluation and management of ADHF to improve patient outcomes.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Acute decompensated heart failure (ADHF) prevalence and associated mortality/morbidity are increasing.
- Projected rise in heart failure (HF) cases to over 8 million Americans by 2030, with costs escalating to $70 billion.
- Demographic shifts and population growth are key drivers of the increasing HF burden.
Purpose of the Study:
- To provide an updated review for clinicians on the evaluation and optimal management of ADHF.
- To address the growing need for evidence-based strategies in ADHF care.
- To synthesize recent findings relevant to ADHF treatment.
Main Methods:
- Review of recent clinical trials and guidelines focused on ADHF management.
- Synthesis of current evidence regarding diagnostic and therapeutic approaches for ADHF.
- Focus on practical updates for clinical practice.
Main Results:
- Recent studies increasingly focus on ADHF management, moving beyond chronic HF research.
- Emerging data provides new insights into optimal diagnostic tools and treatment strategies for ADHF.
- The review consolidates key findings to guide clinical decision-making.
Conclusions:
- Optimal management of ADHF requires updated clinical knowledge.
- Clinicians need to be informed about the latest evidence for effective ADHF evaluation and treatment.
- Addressing the rising burden of ADHF is crucial for improving patient outcomes and reducing healthcare costs.
Abstract:
Acute decompensated heart failure (ADHF) continues to increase in prevalence and is associated with substantial mortality and morbidity including frequent hospitalizations. The American Heart Association is predicting that more than eight million Americans will have heart failure by 2030 and that the total direct costs associated with the disease will rise from $21 billion in 2012 to $70 billion in 2030. The increase in the prevalence and cost of HF is primarily the result of shifting demographics and a growing population. Although many large, randomized, controlled clinical trials have been conducted in patients with chronic heart failure, it was not until recently that a growing number of studies began to address the management of ADHF. It is the intent of this review to update the clinician regarding the evaluation and optimal management of ADHF.
More Related Videos
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure III: Clinical Manifestations
Heart Failure VI: Adjunct Therapies
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VII: Nursing Interventions

